Treatment of Attentional and Hyperactivity Problems in Children with Sympathomimetic Drugs: A Comprehensive Review

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 29, Issue 5, 1990, Pages 677-688

  JACOBVITZ, DEBORAH ^a,b,c   SROUFE, L ALAN ^a,b,c   STEWART, MARK ^a,b,c   LEFFERT, NANCY ^a,b,c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

attention deficit disorder; hyperactivity; methylphenidate; outcome; stimulants; sympathomimetic

Indexed keywords

HALOPERIDOL; METHYLPHENIDATE;

ANOREXIA; ATTENTION DEFICIT DISORDER; CHILD; HEADACHE; HUMAN; HYPERACTIVITY; INSOMNIA; PSYCHOLOGICAL ASPECT; REVIEW; SIDE EFFECT; WEIGHT REDUCTION;

AROUSAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CHILD; FOLLOW-UP STUDIES; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.; SYMPATHOMIMETICS;

EID: 0025006364     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199009000-00001     Document Type: Article

References (130)

1. An evaluation of cognitive behavior therapy for hyperactive children
2. The normalizing effects of methylphenidate on the classroom behavior of ADDH children
3. Hyperactive children treated with stimulants: is cognitive training a useful adjunct?
4. Behavioral and cognitive subtypes of ADHD
5. A four-year follow-up of hyperactive boys with and without conduct disorder
6. Predicting the response of hyperkinetic children to stimulant drugs: a review
7. Hyperactive girls and boys: stimulant drug affects on mother–child interaction
8. Hyperkinesis, autonomic nervous system activity and stimulant drug effects
9. Developmental changes in the mother–child interactions of hyperactive boys: effects of two dose levels of Ritalin
10. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children
11. Teenage alcohol use among hyperactive and nonhyperactive children: a five-year follow-up study
12. Urinary 3-methoxy-4-hydroxyphenylglycol and homovanillic acid response to d-amphetamine in hyperactive children
13. Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration
14. Methylphenidate and cognitive therapy: a comparison of treatment approaches with hyperactive boys
15. Average evoked responses in normal and minimally brain dysfunctioned children treated with amphetamine: a preliminary report
16. Sociometric status of clinic-referred children with attention deficit disorders with and without hyperactivity
17. A four-year follow-up study of the effects of methylphenidate on the behavior an academic achievement of hyperactive children
18. Dyadic peer interaction and task orientation in attention-deficit-disordered children
19. The clinical guide to child psychiatry
20. Evaluations of the relative effectiveness of methylphenidate and cognitive behavior modification in the treatment of kindergarten-aged hyperactive children
21. A controlled study of tourette syndrome. I. Attention-deficit disorder, learning disorders and school problems
22. Discussion of Rapoport's chapter
23. Long-term follow-up of early detected vulnerable children
24. The role of academic failure in hyperactive behavior
25. A developmental dose-response analysis of the effects of methylphenidate on the peer interactions of attention deficit disordered boys
26. Tics following methylphenidate administration
27. Short term effects of methylphenidate on the cognitive learning and academic performance of children with attention deficit disorder in the laboratory and the classroom
28. Dosage effects and individual responsivity to methylphenidate in attention deficit disorder
29. Neuropsychiatric sequelae of acute epidemic encephalitis in children
30. Methylphenidate and the activity of hyperactives in the informal setting
31. The attention disorders and related syndromes. Outcome in adolescence and young adult life
32. Minor physical anomalies in hyperactive, retarded and normal children and their families
33. Methylphenidate effects in learning disabilities. Psychometric changes
34. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height
35. Methylphenidate and growth in hyperactive children: a controlled withdrawal study
36. The effect of central nervous system stimulants on Tourette syndrome
37. Hormone and growth response in hyperkinetic children on stimulant medication
38. Growth hormone, prolactin, and growth responses in hyperkinetic males treated with D-amphetamine
39. Hyperactive children and peer interaction: knowledge and performance of social skills
40. Dextroamphetamine, desipramine, growth, hyperkinetic syndrome, imipramine, methylphenidate
41. Hyperactives as young adults: initial predictors of adult outcome
42. On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in child psychopathology
43. Cognitive-behavioral and pharmacological interventions for hyperactive boys: comparative and combined effects
44. Self-control in hyperactive boys in anger-inducing situations: effect of cognitive-behavioral training and methylphenidate
45. The hyperactive child at adolescence: emotional, social, and cognitive functioning
46. Stimulant effects on cooperation and social interaction between hyperactive children and their mothers
47. The early caregiver–child relationship and Attention Deficit Disorder with Hyperactivity in kindergarten: a prospective study
48. Neuroendocrine aspects of attention deficit hyperactivity disorder
49. Peer relationships in ADDH and normal children: a developmental analysis of peer and teacher ratings
50. Attentional deficits with and without hyperactivity: teacher and peer perceptions
51. Hyperactive boys in their classroom: assessment of teachers and peer perceptions, interactions, and classroom behavior
52. Side effects of antipsychotic drugs and their treatment
53. The predictability of adult mental health from childhood behavior
54. Psychoactive drugs in the immature organism
55. Adolescent outcomes for hyperactive children: perspectives on general and specific patterns of childhood risk for adolescent educational, social and mental health problems
56. Social communication patterns of attention-deficit-disordered boys
57. Performance enhancement by the amphetamines: a new appraisal
58. The hyperactive child grows up: predictors of symptoms, delinquency, and achievement at follow-up
59. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder
60. Stimulant medications precipitate Tourette's syndrome
61. Hyperactive boys almost grown up
62. Drug linked to growth problem in children
63. Animal behavioral/biological models relevant to depression and affective disorders in humans
64. Hyperactive children as teenagers: a follow-up study
65. The hyperactive child syndrome: peripheral sympathetic nervous system function and the effect of d-amphetamine
66. The effects of psychostimulant drugs on learning and academic achievement in children with attention-deficit disorders and learning disabilities
67. Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior
68. Peer relationships in hyperactive children: description and treatment
69. Behavioral and pharmacological treatment of hyperactivity and attention deficit disorders
70. Effects of methylphenidate on normal children's mood, event-related potentials and performance in memory, scanning & vigilance
71. The influence of methylphenidate on heart rate and behavioral measures of attention in hyperactive children
72. Evoked potentials in hyperkinetic and normal under certainty and uncertainty
73. Ritalin vs. response cost in the control of hyperactive children: a within-subject comparison
74. Dextroamphetamine: cognitive and behavioral effects in normal prepurtal boys
75. A 2-year follow-up of 72 hyperactive boys
76. Effects of methylphenidate on underachieving children
77. Effects of Ritalin on underachieving children: a replication
78. Sturdy childhood predictors of adult outcomes: replications from longitudinal studies
79. Plasma testosterone in the male rhesus: influences of sexual and social stimuli
80. Diagnosis and classification: Some outstanding issues
81. A neuropsychiatric study in childhood
82. Factors influencing the suppressant effects of two stimulant drugs on the growth of hyperactive children
83. Trends in medication therapy for hyperactivity: national and international perspectives
84. A survey of medication treatment for hyperactive/inattentive students
85. Depression of growth in hyperactive children on stimulant drugs
86. Growth rebound after termination of stimulant drugs
87. Physiological studies of the hyperkinetic child: I
88. A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys
89. Therapeutic interventions to prevent delinquency in hyperactive boys
90. Situationally and pervasively hyperactive children
91. Hyperactivity in preschoolers and the effect of methylphenidate
92. Do stimulants provoke, cause or exacerbate tics and Tourette Syndrome?
93. The biochemical basis of minimal brain dysfunction
94. Platelet MAO in children with attention deficit disorder and hyperactivity. A pilot study
95. Urinary MHPG excretion in minimal brain dysfunction and its modification by d-amphetamine
96. Neuropharmacological basis of stimulant drug action in deficit disorder with hyperactivity: a review and synthesis
97. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior
98. Drug treatment of children with behavior problems
99. Treating problem children with stimulant drugs
100. The state-dependent and main effects of pemoline and methylphenidate on paired-associate learning and spelling in hyperactive children
101. The Coulstonian Lectures on some abnormal physical conditions in children
102. The interactions of hyperactive and normal boys with their fathers and mothers
103. Attention deficit and conduct disorder syndromes
104. Childhood hyperactivity
105. Long term outcome of hyperkinetic syndrome: empirical findings, conceptual problems and practical implications
106. Enhancement of human performance by caffeine and the amphetamines
107. Effects of long-term treatment of hyperactive children with methylphenidate
108. Studies on the hyperactive child, IV. An empirical analysis of the minimal brain dysfunction syndrome
109. Methylphenidate in hyperactive and enuretic children
110. The social ecology of psychostimulant treatment: a model for conceptual and empirical analysis
111. Behavior observations of hyperactive children and methylphenidate (Ritalin) effects in systematically structured classroom environments: now you see them, now you don't
112. A social ecology of hyperactive boys: medication effects in structured classroom environments
113. Peer interaction in a structure communication tasks. Comparison of normal and hyperactive boys and methylphenidate (Ritalin) and placebo effects
114. Methylphenidate and hyperactivity: effects on teachers' behaviors
115. Teacher response to the methylphenidate (Ritalin) versus placebo status of hyperactive boys in the classroom
116. Urinary 3-methoxy-4-hydroxyphenylglycol sulfate excretion in seventy-three school children with minimal brain dysfunction syndrome
117. Minimal brain dysfunction, stimulant drugs, and autonomic nervous system activity
118. Neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years?
119. Optimal stimulation: a model of disordered activity and performance in normal and deviant children